Literature DB >> 26685773

Developing a Risk Prediction Model for Long-Term Physical and Psychological Functioning after Hematopoietic Cell Transplantation.

Annemarie M J Braamse1, Jean C Yi2, Otto J Visser3, Martijn W Heymans4, Berno van Meijel5, Joost Dekker6, Karen L Syrjala2.   

Abstract

Hematopoietic cell transplantation (HCT) is associated with impaired physical and psychological functioning for some long-term survivors. A risk prediction model would help clinicians estimate their patients' physical and psychological functioning after HCT and determine when to refer to added supportive care when appropriate. The purpose of the present study was to develop risk prediction models for physical and psychological functioning in HCT survivors. This was a secondary analysis of data from a randomized controlled trial (NCT00799461) that included 3- to 10-year HCT survivors. Risk predictions for physical and psychological functioning were developed by using backward logistic regression. The models were internally validated using bootstrapping techniques. Regression coefficients were converted into easy-to-use risk scores. Finally, the sensitivity, specificity, and positive and negative predictive values of the total risk score were calculated. The analyses included 489 survivors, with a mean age of 45.6 (SD, 12.4) years; 47% were female and with a mean of 6.1 years (SD, 2.0) after transplantation. Younger age, higher body mass index (BMI), no or part-time work, more comorbid diseases, autologous transplantation, and chronic graft-versus-host disease predicted impaired physical functioning. Female gender, younger age, higher BMI, not living with a partner, autologous transplantation, and chronic graft-versus-host disease predicted impaired psychological functioning. Although both models had predictive value for long-term functioning, diagnostic accuracy was moderate. For the physical functioning receiver operating characteristic, area under the curve (AUC) after internal validation was .74 with sensitivity 51.9 and specificity 82.8 at the optimal cut-off. For psychological functioning, AUC after internal validation was .69 with sensitivity 83.3 and specificity 42.9 at the optimal cut-off. We conclude that it is possible to predict long-term physical and psychological functioning with readily accessible, mostly pretransplantation predictors. The accuracy of the risk prediction models can be improved for use in clinical practice, potentially by adding pretransplantation patient-reported functioning and comorbidities.
Copyright © 2016 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hematologic neoplasms; Hematopoietic cell transplantation; Quality of life

Mesh:

Year:  2015        PMID: 26685773      PMCID: PMC4753122          DOI: 10.1016/j.bbmt.2015.11.1102

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  47 in total

1.  Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation.

Authors:  Mohamed L Sorror; Rainer F Storb; Brenda M Sandmaier; Richard T Maziarz; Michael A Pulsipher; Michael B Maris; Smita Bhatia; Fabiana Ostronoff; H Joachim Deeg; Karen L Syrjala; Elihu Estey; David G Maloney; Frederick R Appelbaum; Paul J Martin; Barry E Storer
Journal:  J Clin Oncol       Date:  2014-08-25       Impact factor: 44.544

2.  Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).

Authors:  Can-Lan Sun; Liton Francisco; K Scott Baker; Daniel J Weisdorf; Stephen J Forman; Smita Bhatia
Journal:  Blood       Date:  2011-08-05       Impact factor: 22.113

Review 3.  Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up.

Authors:  Smita Bhatia
Journal:  Expert Rev Hematol       Date:  2011-08       Impact factor: 2.929

Review 4.  Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies.

Authors:  A M J Braamse; M M J G Gerrits; B van Meijel; O Visser; P van Oppen; A D Boenink; P Cuijpers; P C Huijgens; A T F Beekman; J Dekker
Journal:  Bone Marrow Transplant       Date:  2011-07-04       Impact factor: 5.483

5.  A disease risk index for patients undergoing allogeneic stem cell transplantation.

Authors:  Philippe Armand; Christopher J Gibson; Corey Cutler; Vincent T Ho; John Koreth; Edwin P Alyea; Jerome Ritz; Mohamed L Sorror; Stephanie J Lee; H Joachim Deeg; Barry E Storer; Frederick R Appelbaum; Joseph H Antin; Robert J Soiffer; Haesook T Kim
Journal:  Blood       Date:  2012-06-18       Impact factor: 22.113

6.  Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.

Authors:  Mohamed L Sorror; Paul J Martin; Rainer F Storb; Smita Bhatia; Richard T Maziarz; Michael A Pulsipher; Michael B Maris; Christopher Davis; H Joachim Deeg; Stephanie J Lee; David G Maloney; Brenda M Sandmaier; Frederick R Appelbaum; Theodore A Gooley
Journal:  Blood       Date:  2014-05-05       Impact factor: 22.113

7.  Development and implementation of an Internet-based survivorship care program for cancer survivors treated with hematopoietic stem cell transplantation.

Authors:  Karen L Syrjala; Allison C Stover; Jean C Yi; Samantha B Artherholt; Eleni M Romano; Gary Schoch; Susan Stewart; Mary E D Flowers
Journal:  J Cancer Surviv       Date:  2011-05-05       Impact factor: 4.442

8.  Associations of calf skeletal muscle characteristics and peripheral nerve function with self-perceived physical functioning and walking ability in persons with peripheral artery disease.

Authors:  Natalie S Evans; Kiang Liu; Michael H Criqui; Luigi Ferrucci; Jack M Guralnik; Lu Tian; Yihua Liao; Mary M McDermott
Journal:  Vasc Med       Date:  2011-02       Impact factor: 3.239

Review 9.  Delivering care to long-term adult survivors of hematopoietic cell transplantation.

Authors:  Karen L Syrjala; Paul J Martin; Stephanie J Lee
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

10.  Comment on 'psychological distress in patients with cancer: is screening the effective solution?'.

Authors:  J Dekker; A T F Beekman; A D Boenink; H Bomhof-Roordink; A M Braamse; E H Collette; P C Huijgens; M H M van der Linden; B van Meijel; F J Snoek; O Visser; H M Verheul
Journal:  Br J Cancer       Date:  2013-06-11       Impact factor: 7.640

View more
  7 in total

1.  Who Enrolls in an Online Cancer Survivorship Program? Reach of the INSPIRE Randomized Controlled Trial for Hematopoietic Cell Transplantation Survivors.

Authors:  Jean C Yi; Brie Sullivan; Wendy M Leisenring; Navneet S Majhail; Heather Jim; Alison Loren; Joseph Uberti; Victoria Whalen; Mary E D Flowers; Stephanie J Lee; Katie Maynard; Karen L Syrjala
Journal:  Biol Blood Marrow Transplant       Date:  2020-06-26       Impact factor: 5.742

2.  Circadian Rhythmicity as a Predictor of Quality of Life in Allogeneic Hematopoietic Cell Transplant Patients.

Authors:  Aasha I Hoogland; Hailey W Bulls; Brian D Gonzalez; Brent J Small; Lianqi Liu; Joseph Pidala; Heather S L Jim; Asmita Mishra
Journal:  J Pain Symptom Manage       Date:  2019-01-31       Impact factor: 3.612

3.  Factors associated with social functioning among long-term cancer survivors treated with hematopoietic stem cell transplantation as adolescents or young adults.

Authors:  Casey A Walsh; Jean C Yi; Abby R Rosenberg; Marie-Laure V Crouch; Wendy M Leisenring; Karen L Syrjala
Journal:  Psychooncology       Date:  2020-08-13       Impact factor: 3.894

Review 4.  Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation.

Authors:  Debra Lynch Kelly; David Buchbinder; Rafael F Duarte; Jeffrey J Auletta; Neel Bhatt; Michael Byrne; Zachariah DeFilipp; Melissa Gabriel; Anuj Mahindra; Maxim Norkin; Helene Schoemans; Ami J Shah; Ibrahim Ahmed; Yoshiko Atsuta; Grzegorz W Basak; Sara Beattie; Sita Bhella; Christopher Bredeson; Nancy Bunin; Jignesh Dalal; Andrew Daly; James Gajewski; Robert Peter Gale; John Galvin; Mehdi Hamadani; Robert J Hayashi; Kehinde Adekola; Jason Law; Catherine J Lee; Jane Liesveld; Adriana K Malone; Arnon Nagler; Seema Naik; Taiga Nishihori; Susan K Parsons; Angela Scherwath; Hannah-Lise Schofield; Robert Soiffer; Jeff Szer; Ida Twist; Anne Warwick; Baldeep M Wirk; Jean Yi; Minoo Battiwalla; Mary E Flowers; Bipin Savani; Bronwen E Shaw
Journal:  Biol Blood Marrow Transplant       Date:  2017-09-20       Impact factor: 5.742

Review 5.  Unmet Needs for Psychosocial Care in Hematologic Malignancies and Hematopoietic Cell Transplant.

Authors:  Anna Barata; William A Wood; Sung Won Choi; Heather S L Jim
Journal:  Curr Hematol Malig Rep       Date:  2016-08       Impact factor: 3.952

Review 6.  Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT.

Authors:  David Buchbinder; Debra Lynch Kelly; Rafael F Duarte; Jeffery J Auletta; Neel Bhatt; Michael Byrne; Zachariah DeFilipp; Melissa Gabriel; Anuj Mahindra; Maxim Norkin; Helene Schoemans; Ami J Shah; Ibrahim Ahmed; Yoshiko Atsuta; Grzegorz W Basak; Sara Beattie; Sita Bhella; Christopher Bredeson; Nancy Bunin; Jignesh Dalal; Andrew Daly; James Gajewski; Robert Peter Gale; John Galvin; Mehdi Hamadani; Robert J Hayashi; Kehinde Adekola; Jason Law; Catherine J Lee; Jane Liesveld; Adriana K Malone; Arnon Nagler; Seema Naik; Taiga Nishihori; Susan K Parsons; Angela Scherwath; Hannah-Lise Schofield; Robert Soiffer; Jeff Szer; Ida Twist; Anne B Warwick; Baldeep M Wirk; Jean Yi; Minoo Battiwalla; Mary D E Flowers; Bipin Savani; Bronwen E Shaw
Journal:  Bone Marrow Transplant       Date:  2018-01-17       Impact factor: 5.483

7.  Driving Distance and Patient-Reported Outcomes in Hematopoietic Cell Transplantation Survivors.

Authors:  Rahul Banerjee; Jean C Yi; Navneet S Majhail; Heather S L Jim; Joseph Uberti; Victoria Whalen; Alison W Loren; Karen L Syrjala
Journal:  Biol Blood Marrow Transplant       Date:  2020-08-08       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.